Where does Pulse Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pulse Biosciences, Inc. ranks #7,464 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pulse Biosciences, Inc. hold?

Pulse Biosciences, Inc. holds 44 US utility patents granted between 2017 and 2025, spanning 12 technology areas.

What is Pulse Biosciences, Inc.'s Innovation Score?

Pulse Biosciences, Inc. has an Innovation Score of 49.7 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pulse Biosciences, Inc. focus on?

Pulse Biosciences, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 41 patents, ranking #90 of 1,943 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Pulse Biosciences, Inc.'s patent grant rate increasing or decreasing?

Pulse Biosciences, Inc.'s recent grant velocity is +210% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Pulse Biosciences, Inc.'s patents?

Pulse Biosciences, Inc.'s patents average 24.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pulse Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Pulse Biosciences, Inc.

USPTO PatentsView assignee record - 44 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pulse ranks #7,464 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 12 technology areas.

#7,464
of 49,997 US assignees by volume: Top 14%
by Innovation Score (49.7/100): 24.7
avg claims per patent: +210%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7464 · US Corporation #7,464 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 44 grants
UPPER-Q #7,464/49,997
PHOTO-FINISH Pivotal Commware
CPC-FOCUS A61N · 12 areas
INNOV-PAR 49.7/100
CLAIMS-DENSE 24.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +210% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pivotal Commware, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pulse’s 49.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (26%) Velocity 9.5 pts (19%) Breadth 12.2 pts (25%) Claim depth 14.8 pts (30%)

Qualcomm Incorporated · highest

85
Kanto Denka Kogyo · near

50
Kodak Alaris · near

50
Maytronics · near

50
Pulse Biosciences · this assignee

50
Suez Groupe · near

50
3D Lighting… · lowest

7

What this shows Pulse's Innovation Score is 49.7/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Pulse?

Each dot is one of Pulse’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pulse’s own 24.7 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pulse vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pulse's grants concentrate

Pulse Biosciences, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 93.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (9 grants) versus a trough of 3 in 2017. By volume, Pulse sits between Pivotal Commware, Inc. and Rondo Energy, Inc..

Pulse's three-year grant acceleration

Pulse Biosciences, Inc. shows 20 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pivotal Commware

44
Portable Multimed…

44
Prismatic Sensors…

44
Protochips

44
Regulus Therapeut…

44
Reliant Immune Di…

44
Roehm

44
Rondo Energy

44
Pulse Biosciences ◀

44

What this shows Pulse holds 44 patents at rank #7,464, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pulse

By rank, the assignees closest to #7,464 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Pulse's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pulse, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Pulse ranks #90 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Kanto Denka Kogyo Co., Ltd. 50 Maytronics Ltd. 50 Suez Groupe 50 Kodak Alaris, LLC 50

Pulse's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Pulse Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	6.8%
2018	4	9.1%
2019	3	6.8%
2020	7	15.9%
2021	4	9.1%
2022	3	6.8%
2023	8	18.2%
2024	9	20.5%
2025partial year	3	6.8%

Which technologies does Pulse Biosciences, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 41

A61B - DIAGNOSIS; SURGERY; Identification 40

H03K - Pulse Technique 15

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07K - Peptides 5

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 2

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 2

G06F - Electric Digital Data Processing 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Pulse Biosciences, Inc.'s patent record in context - here's where to go next.

Pulse Biosciences, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 93.2% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,464 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pulse Biosciences, Inc. against Pivotal Commware, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.